FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1576-1579 May 16, 2002 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Annas, G. J. PubMed Citation

It is rare that a scientific subject causes controversy not only among scientists but also among politicians and the public. Stem-cell biology is such a subject. The media reports new claims as soon as (or before) they appear in the scientific literature or are presented at scientific meetings. Talk-show hosts present their views, and both Congress and the executive branch follow with policy initiatives. But in its present state, there is little certitude in the science of stem cells, and the hard facts are emerging slowly. It is important for the public and policy makers to understand the fundamentals of . . . [Full Text of this Article]

What Are Stem Cells?

Can Tissue-Specific Stem Cells Change Their Fates in Adults?

Human Embryonic Stem Cells in Science and Medicine

Political and Ethical Issues

References

Related Letters:

Therapeutic Cloning
Pellegrino E. D., Kilner J. F., FitzGerald K. T., Bevington L. K., Mitchell C. B., Koop C. E., Meilaender G., Guenin L. M., Donaldson L., Schenk T. M., Weissman I. L., Evers K., Annas G. J.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:1619-1622, Nov 14, 2002. Correspondence

This article has been cited by other articles:

• Duncan, I., Goldman, S, Macklin, W., Rao, M, Weiner, L., Reingold, S. (2008). Stem cell therapy in multiple sclerosis: promise and controversy. Mult Scler 14: 541-546 [Abstract]  
• Kwan, M. D., Slater, B. J., Wan, D. C., Longaker, M. T. (2008). Cell-based therapies for skeletal regenerative medicine. Hum Mol Genet 17: R93-R98 [Abstract] [Full Text]  
• Gargett, C.E. (2007). Uterine stem cells: What is the evidence?. Hum Reprod Update 13: 87-101 [Abstract] [Full Text]  
• Sprigg, N., Bath, P. M., Zhao, L., Willmot, M. R., Gray, L. J., Walker, M. F., Dennis, M. S., Russell, N. (2006). Granulocyte-Colony-Stimulating Factor Mobilizes Bone Marrow Stem Cells in Patients With Subacute Ischemic Stroke: The Stem Cell Trial of Recovery EnhanceMent After Stroke (STEMS) Pilot Randomized, Controlled Trial (ISRCTN 16784092). Stroke 37: 2979-2983 [Abstract] [Full Text]  
• Weissman, I. (2005). Stem Cell Research: Paths to Cancer Therapies and Regenerative Medicine. JAMA 294: 1359-1366 [Abstract] [Full Text]  
• Davani, S., Deschaseaux, F., Chalmers, D., Tiberghien, P., Kantelip, J.-P. (2005). Can stem cells mend a broken heart?. Cardiovasc Res 65: 305-316 [Abstract] [Full Text]  
• Strom, T. B., Field, L. J., Ruediger, M. (2004). Allogeneic Stem Cell-Derived "Repair Unit" Therapy and the Barriers to Clinical Deployment. J. Am. Soc. Nephrol. 15: 1133-1139 [Abstract] [Full Text]  
• Sylvester, K. G., Longaker, M. T. (2004). Stem Cells: Review and Update. Arch Surg 139: 93-99 [Abstract] [Full Text]  
• Pellegrino, E. D., Kilner, J. F., FitzGerald, K. T., Bevington, L. K., Mitchell, C. B., Koop, C. E., Meilaender, G., Guenin, L. M., Donaldson, L., Schenk, T. M., Weissman, I. L., Evers, K., Annas, G. J. (2002). Therapeutic Cloning. NEJM 347: 1619-1622 [Full Text]  
• Annas, G. J. (2002). Cloning and the U.S. Congress. NEJM 346: 1599-1602 [Full Text]